Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

Use and effects of cannabinoids in military veterans with posttraumatic stress disorder

(2015) K. Betthauser et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

(2015) A.L.Z. Marinho et al.   BEHAVIOURAL BRAIN RESEARCH

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

(2015) John M McPartland et al.   BRITISH JOURNAL OF PHARMACOLOGY

Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit

(2015) Laura G Rosen et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine

(2015) J. F. C. Pedrazzi et al.   PSYCHOPHARMACOLOGY

Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol

(2015) Felipe V. Gomes et al.   SCHIZOPHRENIA RESEARCH

Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area

(2014) B. Draycott et al.   JOURNAL OF NEUROSCIENCE

Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction

(2014) Michael Loureiro et al.   NEUROPSYCHOPHARMACOLOGY

Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats

(2014) Stephanie Mijangos-Moreno et al.   NEUROSCIENCE RESEARCH

HIGHER IN VIVO SEROTONIN-1A BINDING IN POSTTRAUMATIC STRESS DISORDER: A PET STUDY WITH [11C]WAY-100635

(2013) Gregory M. Sullivan et al.   DEPRESSION AND ANXIETY

Cannabidiol as a potential treatment for psychosis

(2013) C.D. Schubart et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience

(2013) M.V. Fogaça et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cannabidiol enhances consolidation of explicit fear extinction in humans

(2013) Ravi K. Das et al.   PSYCHOPHARMACOLOGY

Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1Areceptors in the dorsal raphe nucleus

(2012) Vicky Katsidoni et al.   ADDICTION BIOLOGY

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2012) Sagnik Bhattacharyya   ARCHIVES OF GENERAL PSYCHIATRY

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

(2012) Antonio Waldo Zuardi et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors

(2012) Alline Cristina Campos et al.   JOURNAL OF PSYCHIATRIC RESEARCH

On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment

(2012) Cristina A J Stern et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Neuronal circuits underlying acute morphine action on dopamine neurons

(2011) M. Jalabert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol

(2009) Sagnik Bhattacharyya et al.   ARCHIVES OF GENERAL PSYCHIATRY

Biologically Active Cannabinoids from High-PotencyCannabis sativa

(2009) Mohamed M. Radwan et al.   JOURNAL OF NATURAL PRODUCTS

Dopamine D1 versus D4 Receptors Differentially Modulate the Encoding of Salient versus Nonsalient Emotional Information in the Medial Prefrontal Cortex

(2009) N. M. Lauzon et al.   JOURNAL OF NEUROSCIENCE

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

(2009) Samira S Valvassori et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

(2008) Rafael M. Bitencourt et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects

(2008) Huibing Tan et al.   NEUROPHARMACOLOGY

5-HT1A and 5-HT1B receptors in the ventrolateral striatum differentially modulate apomorphine-induced jaw movements in rats

(2008) Satoshi Fujita et al.   Journal of Oral Science

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY